Steven K. Libutti

21.8k citations
339 papers · 16.4k · 2 hit papers · h-index 70

Impact in

    • Cancer, Hypoxia, and Metabolism
  • Oncology top 0.5%
    • Pancreatic and Hepatic Oncology Research

Papers in

    • Angiogenesis and VEGF in Cancer 36
    • Pancreatic and Hepatic Oncology Research 21
    • Lung Cancer Research Studies 15

Steven K. Libutti

334 papers receiving 15.8k citations

Steven K. Libutti's Hit Papers

Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine 2010 · 602 citations
6020+7+15Years since publication2505007501000

Peers

Steven K. Libutti
Comparison fields: 5 of 159
  • Cancer Research 2.4k
  • Oncology 3.9k
  • Nephrology 941
  • Neurology 1.6k
  • Epidemiology 3.0k
Replace Gavin Thurston with:
Gavin Thurston United States
Anthony D. Ho Germany
Masashi Fukayama Japan
Maria J. Merino United States
Douglas B. Cines United States
Marsha A. Moses United States
Noel Weidner United States
Elena Aïkawa United States
Edward F. Plow United States
Catherine Sautès‐Fridman France
Steven K. Libutti relative to Gavin Thurston United States Gavin Thurston's profile →
Citations per field
00.5×4.2×
Gavin Thurston · 1×
Citations per year

Countries citing papers authored by Steven K. Libutti

Since Specialization
Citations

This map shows the geographic impact of Steven K. Libutti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven K. Libutti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven K. Libutti more than expected).

Fields of papers citing papers by Steven K. Libutti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven K. Libutti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven K. Libutti. The network helps show where Steven K. Libutti may publish in the future.

Co-authors

The 25 scholars most cited alongside Steven K. Libutti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steven K. Libutti Line = papers co-authored together Steven K. Libutti links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 339 papers — load more, or switch the sort, to bring in the rest.

#Work
1
von Hippel-Lindau disease
Hit paper breakdown →
20031169
2
Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
Hit paper breakdown →
2010602
3 2007423
4 2001384
5
Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes.
2001306
6 2003291
7 2019244
8 2009231
9 1998205
10 2007200
11 2002195
12 2003184
13 2000176
14 1998169
15 1994163
16 1998156
17 2002155
18 1999142
19 2007142
20 2003142

About Steven K. Libutti

Steven K. Libutti is a scholar working on Molecular Biology, Oncology, Epidemiology, Surgery and Cancer Research, having authored 339 papers that have together received 16.4k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (60 papers), Angiogenesis and VEGF in Cancer (36 papers), Neuroblastoma Research and Treatments (29 papers), Cancer, Hypoxia, and Metabolism (24 papers), Pancreatic and Hepatic Oncology Research (21 papers), Parathyroid Disorders and Treatments (21 papers), Hepatocellular Carcinoma Treatment and Prognosis (16 papers) and Lung Cancer Research Studies (15 papers). The work is most often cited by research in Cancer Research (2.4k citations), Oncology (3.9k citations), Nephrology (941 citations), Neurology (1.6k citations) and Epidemiology (3.0k citations). Steven K. Libutti has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include H. Richard Alexander, McClellan M. Walther, Peter L. Choyke, David L. Bartlett, G.M. Glenn, Andrew L. Feldman, W. Marston Linehan, Russell R. Lonser, Edward H. Oldfield and Emily Y. Chew. Their work appears in journals such as Surgery, Annals of Surgical Oncology, Journal of Clinical Oncology, Cancer and Journal of the American College of Surgeons.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact